Designing for Access: Embedding Market Access Strategy into CNS Evidence Generation from Phase II Onward
Time: 9:00 am
day: Conference Day One
Details:
- Integrating market access strategy, education and networking early into clinical infrastructure to prevent post-approval access hurdles
- Aligning pivotal trial design and package insert content with downstream payer expectations
- Using advisory boards, consultants, and early payer engagement to shape evidence generation
- Embedding market access considerations into Phase IIb–III decisions without disrupting regulatory-first priorities
